Microbially derived artemisinin: a biotechnology solution to the global problem of access to affordable antimalarial drugs.
about
Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium.High-level production of amorpha-4,11-diene, a precursor of the antimalarial agent artemisinin, in Escherichia coliUp to the challenge? Rising prices for food and oil could herald a renaissance of plant science.An enzymatic platform for the synthesis of isoprenoid precursors.Artemisinin combination therapies price disparity between government and private health sectors and its implication on antimalarial drug consumption pattern in Morogoro Urban District, Tanzania.21st century natural product research and drug development and traditional medicinesProduction of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin.Identification and treatment of heme depletion attributed to overexpression of a lineage of evolved P450 monooxygenasesPredicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies.Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up.Methylerythritol phosphate pathway of isoprenoid biosynthesis.Synthetic biology: enormous possibility, exaggerated perils.Is the grass greener on the other side? Encouraging the development of synthetic biology in EuropeTranslational synthetic biology.Metabolic analyses elucidate non-trivial gene targets for amplifying dihydroartemisinic acid production in yeast.In vitro reconstitution guide for targeted synthetic metabolism of chemicals, nutraceuticals and drug precursors.Approaches and Recent Developments for the Commercial Production of Semi-synthetic Artemisinin.Engineering metabolic pathways in Amycolatopsis japonicum for the optimization of the precursor supply for heterologous brasilicardin congeners production.
P2860
Q21034066-0C90B923-BF92-4D81-BE85-E68B35CA7400Q21143865-E1A451BE-0FFA-4DC2-B8FC-B40A1CDEA897Q28757231-15DAF3B4-8670-415A-99AC-53B38FB9329CQ34083903-39CBDBA2-B63C-4794-A1AA-4C1926727C02Q34210653-1AE577C0-BF75-48B3-AF4D-6A998F7A9369Q34602021-75C12146-84DD-4D11-A439-059F2B712548Q34635129-9E0C8896-4AAB-44BA-A109-AA2B7A54D4B7Q36436881-30070D59-A1A4-4B1C-94D2-A8DE651BF802Q36511836-15A96915-C2CC-4E43-96A8-2A021CC26DF1Q36565244-B3B050FB-643F-4D38-B7C1-DAB745857F80Q37272872-B4D74FAD-F9FE-41CE-8566-FC9EA4586783Q38277272-F8F52D29-BF92-4A80-AB77-8C6447DD14E2Q41935241-7144F432-000F-40BF-83D9-EC8C3AA04222Q42365674-02CF361B-0DDE-4745-A02D-5C448AF1F9E6Q43073354-A552BBA2-EDFA-4107-ADCC-DEBDA144C1B9Q45981589-6572EF96-C419-4D31-AA28-8157B4FA8433Q49291649-5D51A5EB-80C4-4DED-80AF-38C346371E4DQ55361494-D648AF47-C03A-43BD-A62F-47E9756891F1
P2860
Microbially derived artemisinin: a biotechnology solution to the global problem of access to affordable antimalarial drugs.
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Microbially derived artemisini ...... affordable antimalarial drugs.
@ast
Microbially derived artemisini ...... affordable antimalarial drugs.
@en
Microbially derived artemisini ...... affordable antimalarial drugs.
@nl
type
label
Microbially derived artemisini ...... affordable antimalarial drugs.
@ast
Microbially derived artemisini ...... affordable antimalarial drugs.
@en
Microbially derived artemisini ...... affordable antimalarial drugs.
@nl
prefLabel
Microbially derived artemisini ...... affordable antimalarial drugs.
@ast
Microbially derived artemisini ...... affordable antimalarial drugs.
@en
Microbially derived artemisini ...... affordable antimalarial drugs.
@nl
P2093
P921
P1476
Microbially derived artemisini ...... affordable antimalarial drugs.
@en
P2093
Jay D Keasling
Neil Renninger
Thierry T Diagana
Victoria Hale
P304
P407
P433
P577
2007-12-01T00:00:00Z